Applying causal discovery to single-cell analyses using CausalCell

  1. Yujian Wen
  2. Jielong Huang
  3. Shuhui Guo
  4. Yehezqel Elyahu
  5. Alon Monsonego
  6. Hai Zhang  Is a corresponding author
  7. Yanqing Ding  Is a corresponding author
  8. Hao Zhu  Is a corresponding author
  1. Southern Medical University, China
  2. Ben-Gurion University of the Negev, Israel

Abstract

Correlation between objects is prone to occur coincidentally, and exploring correlation or association in most situations does not answer scientific questions rich in causality. Causal discovery (also called causal inference) infers causal interactions between objects from observational data. Inferred causal interactions in single cells provide valuable clues for investigating molecular interaction and gene regulation, identifying critical diagnostic and therapeutic targets, and designing experimental and clinical interventions. The report of causal discovery methods and generation of single-cell data make applying causal discovery to single-cells a promising direction. However, how to evaluate and choose causal discovery methods and how to develop workflow and platform remain challenges. We report the workflow and platform CausalCell (http://www.gaemons.net/causalcell/causalDiscovery/) for performing single-cell causal discovery. The workflow/platform is developed upon benchmarking four kinds of causal discovery methods and is examined by analysing multiple scRNA-seq datasets. Our results suggest that different situations call for different methods and the constraint-based PC algorithm plus kernel-based conditional independence tests suit for most situations. Relevant issues are discussed and tips for best practices are recommended.

Data availability

Only public data were used. Links to all data are provided in the manuscript.

The following previously published data sets were used

Article and author information

Author details

  1. Yujian Wen

    Bioinformatics Section, Southern Medical University, Guangzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Jielong Huang

    Bioinformatics Section, Southern Medical University, Guangzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  3. Shuhui Guo

    Bioinformatics Section, Southern Medical University, Guangzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Yehezqel Elyahu

    The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel
    Competing interests
    The authors declare that no competing interests exist.
  5. Alon Monsonego

    The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel
    Competing interests
    The authors declare that no competing interests exist.
  6. Hai Zhang

    Network Center, Southern Medical University, Guangzhou, China
    For correspondence
    zhangh@smu.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
  7. Yanqing Ding

    Department of Pathology, Southern Medical University, Guangzhou, China
    For correspondence
    dyqgz@126.com
    Competing interests
    The authors declare that no competing interests exist.
  8. Hao Zhu

    Bioinformatics Section, Southern Medical University, Guangzhou, China
    For correspondence
    zhuhao@smu.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7384-3840

Funding

National Natural Science Foundation of China (31771456)

  • Hao Zhu

Department of Science and Technology of Guangdong Province (2020A1515010803)

  • Hao Zhu

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Babak Momeni, Boston College, United States

Version history

  1. Received: June 28, 2022
  2. Preprint posted: August 19, 2022 (view preprint)
  3. Accepted: May 1, 2023
  4. Accepted Manuscript published: May 2, 2023 (version 1)
  5. Version of Record published: May 30, 2023 (version 2)

Copyright

© 2023, Wen et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,123
    views
  • 250
    downloads
  • 2
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yujian Wen
  2. Jielong Huang
  3. Shuhui Guo
  4. Yehezqel Elyahu
  5. Alon Monsonego
  6. Hai Zhang
  7. Yanqing Ding
  8. Hao Zhu
(2023)
Applying causal discovery to single-cell analyses using CausalCell
eLife 12:e81464.
https://doi.org/10.7554/eLife.81464

Share this article

https://doi.org/10.7554/eLife.81464

Further reading

    1. Computational and Systems Biology
    2. Medicine
    Zachary Shaffer, Roberto Romero ... Nardhy Gomez-Lopez
    Research Article

    Background:

    Preterm birth is the leading cause of neonatal morbidity and mortality worldwide. Most cases of preterm birth occur spontaneously and result from preterm labor with intact (spontaneous preterm labor [sPTL]) or ruptured (preterm prelabor rupture of membranes [PPROM]) membranes. The prediction of spontaneous preterm birth (sPTB) remains underpowered due to its syndromic nature and the dearth of independent analyses of the vaginal host immune response. Thus, we conducted the largest longitudinal investigation targeting vaginal immune mediators, referred to herein as the immunoproteome, in a population at high risk for sPTB.

    Methods:

    Vaginal swabs were collected across gestation from pregnant women who ultimately underwent term birth, sPTL, or PPROM. Cytokines, chemokines, growth factors, and antimicrobial peptides in the samples were quantified via specific and sensitive immunoassays. Predictive models were constructed from immune mediator concentrations.

    Results:

    Throughout uncomplicated gestation, the vaginal immunoproteome harbors a cytokine network with a homeostatic profile. Yet, the vaginal immunoproteome is skewed toward a pro-inflammatory state in pregnant women who ultimately experience sPTL and PPROM. Such an inflammatory profile includes increased monocyte chemoattractants, cytokines indicative of macrophage and T-cell activation, and reduced antimicrobial proteins/peptides. The vaginal immunoproteome has improved predictive value over maternal characteristics alone for identifying women at risk for early (<34 weeks) sPTB.

    Conclusions:

    The vaginal immunoproteome undergoes homeostatic changes throughout gestation and deviations from this shift are associated with sPTB. Furthermore, the vaginal immunoproteome can be leveraged as a potential biomarker for early sPTB, a subset of sPTB associated with extremely adverse neonatal outcomes.

    Funding:

    This research was conducted by the Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS) under contract HHSN275201300006C. ALT, KRT, and NGL were supported by the Wayne State University Perinatal Initiative in Maternal, Perinatal and Child Health.

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Ardalan Naseri, Degui Zhi, Shaojie Zhang
    Research Article

    Runs of homozygosity (ROH) segments, contiguous homozygous regions in a genome were traditionally linked to families and inbred populations. However, a growing literature suggests that ROHs are ubiquitous in outbred populations. Still, most existing genetic studies of ROH in populations are limited to aggregated ROH content across the genome, which does not offer the resolution for mapping causal loci. This limitation is mainly due to a lack of methods for the efficient identification of shared ROH diplotypes. Here, we present a new method, ROH-DICE, to find large ROH diplotype clusters, sufficiently long ROHs shared by a sufficient number of individuals, in large cohorts. ROH-DICE identified over 1 million ROH diplotypes that span over 100 SNPs and are shared by more than 100 UK Biobank participants. Moreover, we found significant associations of clustered ROH diplotypes across the genome with various self-reported diseases, with the strongest associations found between the extended HLA region and autoimmune disorders. We found an association between a diplotype covering the HFE gene and hemochromatosis, even though the well-known causal SNP was not directly genotyped or imputed. Using a genome-wide scan, we identified a putative association between carriers of an ROH diplotype in chromosome 4 and an increase in mortality among COVID-19 patients (P-value=1.82×10-11). In summary, our ROH-DICE method, by calling out large ROH diplotypes in a large outbred population, enables further population genetics into the demographic history of large populations. More importantly, our method enables a new genome-wide mapping approach for finding disease-causing loci with multi-marker recessive effects at a population scale.